Xeris Biopharma Holdings, Inc. (FRA:2B30)
Germany · Delayed Price · Currency is EUR 6.38
-0.04 (-0.70%)
At close: Jan 23, 2026
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of €1.03 billion as of January 30, 2026. Its market cap has increased by 118.96% in one year.
Market Cap
1.03B
Enterprise Value
1.17B
Revenue
226.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.38
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from 256.47M to 1.03B, an increase of 300.79%. That is a compound annual growth rate of 37.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.03B | -7.34% |
| Dec 31, 2025 | 1.11B | 127.25% |
| Dec 31, 2024 | 488.15M | 66.23% |
| Dec 29, 2023 | 293.66M | 73.53% |
| Dec 30, 2022 | 169.23M | -47.33% |
| Dec 31, 2021 | 321.29M | 25.28% |
| Oct 6, 2021 | 256.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gelsenwasser AG | 1.80B |
| tonies SE | 1.14B |
| Sedlmayr Grund und Immobilien AG | 932.55M |
| Berliner Effektengesellschaft AG | 879.96M |
| Northern Data AG | 842.90M |
| Maschinenfabrik Berthold Hermle AG | 830.00M |
| Paul Hartmann AG | 763.62M |
| EUROKAI GmbH & Co. KGaA | 707.09M |